Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Kinder Morgan Inc (KMI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Kinder Morgan Inc — how do they compare? Hinge Health Inc. Class A Common Stock trades at $104.95 (market cap $8.48B), while Kinder Morgan Inc trades at $33.37 (market cap $74.44B). The key difference: Kinder Morgan Inc is far larger — about 8.8× Hinge Health Inc. Class A Common Stock's market cap, and Kinder Morgan Inc pays a 3.53% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Kinder Morgan Inc for 151 Days on average.
| HNGE | KMI | |
|---|---|---|
Market Cap | $8.48B | $74.44B |
Volume | 879,799 | 10,771,998 |
Sector | Health | Energy |
52-Week High | $105.14 | $34.31 |
52-Week Low | $31.17 | $25.84 |
Typical Hold Time | 0 Days | 151 Days |
Enterprise Value | $8.10B | $106.49B |
Dividend Yield | — | 3.53% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Kinder Morgan (KMI) trades at $33.35, up 0.82% with a bullish technical outlook. The company delivered three consecutive earnings beats in 2026, with Q3 results pending. Revenue grew to $16.94B in 2025, while net income reached $3.06B. Analyst consensus is mixed with a $37.20 price target, representing 11.5% upside. Recent news highlights the company's $6B-$7B growth pipeline and resilience amid energy market volatility.
KMI offers income investors a compelling opportunity with strong cash flows and a visible growth backlog, though elevated debt levels and energy market sensitivity present risks. The stock's current valuation appears reasonable relative to peers, with technical indicators supporting near-term bullish momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Kinder Morgan Inc
Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →
